ATE469647T1 - Thienoä3,2-cüpyridin-7-carbonsäure-derivate - Google Patents

Thienoä3,2-cüpyridin-7-carbonsäure-derivate

Info

Publication number
ATE469647T1
ATE469647T1 AT07787965T AT07787965T ATE469647T1 AT E469647 T1 ATE469647 T1 AT E469647T1 AT 07787965 T AT07787965 T AT 07787965T AT 07787965 T AT07787965 T AT 07787965T AT E469647 T1 ATE469647 T1 AT E469647T1
Authority
AT
Austria
Prior art keywords
thienoa3
cupyridine
acid derivatives
carbonic acid
ring
Prior art date
Application number
AT07787965T
Other languages
English (en)
Inventor
David Joseph Bartkovitz
Yi Chen
Xin-Jie Chu
Kin-Chun Thomas Luk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE469647T1 publication Critical patent/ATE469647T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT07787965T 2006-08-08 2007-07-27 Thienoä3,2-cüpyridin-7-carbonsäure-derivate ATE469647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83636006P 2006-08-08 2006-08-08
PCT/EP2007/057748 WO2008017594A1 (en) 2006-08-08 2007-07-27 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
ATE469647T1 true ATE469647T1 (de) 2010-06-15

Family

ID=38606469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07787965T ATE469647T1 (de) 2006-08-08 2007-07-27 Thienoä3,2-cüpyridin-7-carbonsäure-derivate

Country Status (14)

Country Link
US (1) US7994321B2 (de)
EP (1) EP2051711B1 (de)
JP (1) JP5091237B2 (de)
KR (1) KR101101725B1 (de)
CN (1) CN101500562B (de)
AT (1) ATE469647T1 (de)
AU (1) AU2007283714B2 (de)
BR (1) BRPI0715397A2 (de)
CA (1) CA2658285C (de)
DE (1) DE602007006962D1 (de)
ES (1) ES2344324T3 (de)
IL (1) IL196418A0 (de)
MX (1) MX2009001141A (de)
WO (1) WO2008017594A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505728B2 (en) 2012-03-09 2016-11-29 Inception 2, Inc. Triazolone compounds and uses thereof
KR20150046056A (ko) * 2012-08-24 2015-04-29 에프. 호프만-라 로슈 아게 신규한 바이사이클릭피리딘 유도체
AU2013363398B2 (en) 2012-12-20 2017-06-01 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
EA201690230A1 (ru) 2013-09-06 2016-07-29 Инсепшн 2, Инк. Соединения триазолона и их применения
EP3634417B1 (de) 2017-05-17 2023-07-12 Arcus Biosciences, Inc. Chinazolin-pyrazolderivate zur behandlung von krebsbedingten erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592352B2 (en) 2003-05-06 2009-09-22 Smithkline Beecham Corporation Substituted thieno and furo-pyridines
US20050026944A1 (en) 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
RU2006142741A (ru) 2004-05-04 2008-06-10 Ф.Хоффманн-Ля Рош Аг (Ch) Тиенопиридины как ингибиторы ikk
US20050256154A1 (en) 2004-05-04 2005-11-17 Kin-Chun Luk 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
CA2601983A1 (en) 2005-04-06 2006-10-12 Astrazeneca Ab Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors

Also Published As

Publication number Publication date
US7994321B2 (en) 2011-08-09
JP2010500316A (ja) 2010-01-07
AU2007283714B2 (en) 2013-01-10
KR101101725B1 (ko) 2012-01-05
BRPI0715397A2 (pt) 2013-11-26
JP5091237B2 (ja) 2012-12-05
EP2051711A1 (de) 2009-04-29
ES2344324T3 (es) 2010-08-24
DE602007006962D1 (en) 2010-07-15
WO2008017594A1 (en) 2008-02-14
IL196418A0 (en) 2009-09-22
CA2658285A1 (en) 2008-02-14
US20080045562A1 (en) 2008-02-21
KR20090033890A (ko) 2009-04-06
AU2007283714A1 (en) 2008-02-14
MX2009001141A (es) 2009-02-10
CN101500562B (zh) 2012-01-25
EP2051711B1 (de) 2010-06-02
CA2658285C (en) 2016-08-23
CN101500562A (zh) 2009-08-05

Similar Documents

Publication Publication Date Title
BRPI0717266A2 (pt) Derivados de oxindol
MX2009004766A (es) Derivados de espiroindolinona.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
BRPI0821255A2 (pt) Derivados de espiroindolinona
ATE524470T1 (de) Spiroindolinonderivate als antikrebsmittel
TW200738695A (en) Cis-4,5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
ATE528290T1 (de) Spiroindolinon-derivate
ATE495176T1 (de) Spiroindolinon-derivate
CR9980A (es) Imidazolinas 4,4,5,5 tetrasustituidas
TNSN08407A1 (en) Organic compounds
MY165238A (en) Substituted pyrrolidine-2-carboxamides
AU2008235089A8 (en) Insecticidal aryl isoxazoline derivatives
HRP20120323T1 (en) Diarylhydantoin compounds
IN2012DN02487A (de)
MX341133B (es) Compuestos y metodos para la inhibición de hdac.
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
UA105647C2 (uk) Арилпіперазини і їх застосування як антагоністів альфа2c
ATE469647T1 (de) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
TW200744612A (en) New combination
WO2008019030A8 (en) Modified azole compounds as antiinfective agents
ATE489391T1 (de) Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2- cüpyridin-7-carbonsäurederivate
UY29805A1 (es) Derivados de quinolinas, composiciones farmacéuticas conteniéndolas, procesos de preparación y aplicaciones
MX2009002606A (es) Derivados de arginina con actividad antagonistica de np-1.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2051711

Country of ref document: EP